Monoclonal Antibodies Against Human Osteosarcoma: Preliminary Studies
Osteosarcoma is a highly malignant tumor that mainly affects young people. Until the introduction of the preoperative high-dose methotrexate treatment the prognosis was dismal. Even with current treatment many patients respond poorly to chemotherapy and rapidly develop metastases. Clearly, this is a disease where new approaches are sorely needed.
KeywordsSynovial Sarcoma Malignant Fibrous Histiocytoma Human Osteogenic Sarcoma Cell Line Distinct Image Freeze Tissue Section
Unable to display preview. Download preview PDF.
- Bruland, O., Fodstad, O., Skretting, A., and Pihl, A., 1987, Selective localization of two radiolabeled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts, Brit. J. Cancer (in press).Google Scholar